Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parasitic Diseases
  Free Subscription

Articles published in
Antimicrob Agents Chemother
    June 2026
  1. SHAFI S, Maurya P, Bansal R, Sharma J, et al
    Selective targeting of Plasmodium falciparum hexose transporter by phytochemical Ginsenoside Rg1 disrupts glucose metabolism and blocks development of parasite.
    Antimicrob Agents Chemother. 2026 Jun 12:e0172725. doi: 10.1128/aac.01727.
    >> Share

    March 2026
  2. SALAZAR YEAR, Rezende AM, Puca MCSB, Louzada J, et al
    Emergence of artemisinin-based combination therapy resistance markers in Plasmodium falciparum from the Brazilian tri-border region of the Guiana Shield.
    Antimicrob Agents Chemother. 2026 Mar 12:e0152525. doi: 10.1128/aac.01525.
    >> Share

    February 2026
  3. SRISUTHAM S, Suwannasin K, Saejeng A, Khantikul N, et al
    Changing genetic profiles of Plasmodium falciparum piperaquine resistance in Southeast Asia over 25 years.
    Antimicrob Agents Chemother. 2026 Feb 17:e0111725. doi: 10.1128/aac.01117.
    >> Share

    October 2025
  4. MESQUITA JT, Moura GC, Cavalcante T, Yokoyama Yasunaka JKU, et al
    In vitro and in vivo study of the inhibition of ubiquinone biosynthesis in Leishmania (Leishmania) amazonensis using the combination of buparvaquone and 4-nitrobenzoate as a strategy for the discovery of new therapeutic targets.
    Antimicrob Agents Chemother. 2025 Oct 7:e0082425. doi: 10.1128/aac.00824.
    >> Share

    September 2025
  5. JUNAID IT, Panda A, Deshmukh A, Sardar R, et al
    Role of novel mutations in food vacuole transporters beyond K13-mediated artemisinin resistance in Plasmodium falciparum.
    Antimicrob Agents Chemother. 2025 Sep 30:e0029325. doi: 10.1128/aac.00293.
    >> Share

    August 2025
  6. NIKOLOVA V, Linnemannstons K, Zahoruiko A, Ganter M, et al
    Synergistic activity of RSL3 and Pyrimethamine to inhibit the proliferation of Plasmodium falciparum.
    Antimicrob Agents Chemother. 2025 Aug 18:e0047125. doi: 10.1128/aac.00471.
    >> Share

    July 2025
  7. MAO EY, Nguyen W, Jana GP, Maity BC, et al
    Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites.
    Antimicrob Agents Chemother. 2025 Jul 25:e0178324. doi: 10.1128/aac.01783.
    >> Share

  8. MACHADO PDA, Gomes PS, Granato JdT, Lemos ASdO, et al
    Exploring the in vitro and in vivo antileishmanial potential of Marizomib against Leishmania amazonensis and Leishmania infantum.
    Antimicrob Agents Chemother. 2025 Jul 21:e0028625. doi: 10.1128/aac.00286.
    >> Share

    June 2025
  9. SPRINGER E, Heimsch KC, Sidiropoulos N, Krijnse Locker J, et al
    Arylmethylamino steroid compound 1o interferes with Plasmodium falciparum's hemoglobin metabolism.
    Antimicrob Agents Chemother. 2025 Jun 23:e0033225. doi: 10.1128/aac.00332.
    >> Share

    May 2025
  10. SIDDIQUI FA, Chim-Ong A, Wang C, Miao J, et al
    The PfK13 G533S mutation confers artemisinin partial resistance in multiple genetic backgrounds of Plasmodium falciparum.
    Antimicrob Agents Chemother. 2025 May 27:e0016225. doi: 10.1128/aac.00162.
    >> Share

  11. RAZZAQ S, Olmo F, Lakshminarayana SB, Ying-Bo C, et al
    Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection.
    Antimicrob Agents Chemother. 2025;69:e0013525.
    >> Share

    April 2025
  12. VAN LOON W, Schallenberg E, Mande E, Musinguzi P, et al
    Plasmodium falciparum Kelch-13 artemisinin partial resistance markers in Fort Portal, Western Uganda, 2024.
    Antimicrob Agents Chemother. 2025 Apr 23:e0175524. doi: 10.1128/aac.01755.
    >> Share

  13. PROELLOCHS NI, Andolina C, Ramjith J, Stoter R, et al
    Gametocyte production and transmission fitness of African and Asian Plasmodium falciparum isolates with differential susceptibility to artemisinins.
    Antimicrob Agents Chemother. 2025 Apr 22:e0193024. doi: 10.1128/aac.01930.
    >> Share

  14. KOJOM FOKO LP, Jakhan J, Narang G, Hawadak J, et al
    Novel Plasmodium falciparum Kelch13 polymorphisms in Cameroon with structural and physicochemical impact.
    Antimicrob Agents Chemother. 2025 Apr 14:e0088424. doi: 10.1128/aac.00884.
    >> Share

    February 2025
  15. HIRAI M, Arai M, Hayamichi S, Uchida A, et al
    Deletion of the chloroquine resistance transporter gene confers reduced piperaquine susceptibility to the rodent malaria parasite Plasmodium berghei.
    Antimicrob Agents Chemother. 2025 Feb 24:e0158924. doi: 10.1128/aac.01589.
    >> Share

  16. KIBOI D, Sa JM, Nayak A, Micchelli CE, et al
    Isolation and characterization of Plasmodium falciparum blood-stage persisters by improved selection protocols using dihydroartemisinin alone.
    Antimicrob Agents Chemother. 2025 Feb 10:e0005324. doi: 10.1128/aac.00053.
    >> Share

  17. PALOQUE L, Mathieu L, Laurent M, Coppee R, et al
    Artemisinin pressure in field isolates can select highly resistant Plasmodium falciparum parasites with unconventional phenotype and no K13 mutation.
    Antimicrob Agents Chemother. 2025 Feb 4:e0154124. doi: 10.1128/aac.01541.
    >> Share

    January 2025
  18. KAR PP, Araveti PB, Saxena K, Borah A, et al
    Erratum for Kar et al., "Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7".
    Antimicrob Agents Chemother. 2025 Jan 24:e0178224. doi: 10.1128/aac.01782.
    >> Share

    December 2024
  19. OBONYO CO, Were VO, Wamae P, Muok EMO, et al
    Efficacy and safety of praziquantel plus artemisinin-based combinations versus praziquantel in the treatment of Kenyan children with Schistosoma mansoni infection: open-label, randomized, head-to-head, non-inferiority trial.
    Antimicrob Agents Chemother. 2024 Dec 19:e0073924. doi: 10.1128/aac.00739.
    >> Share

  20. SAYEED A, Atkinson R, Vekilov PG, Rimer JD, et al
    Stage-specific pharmacodynamic chloroquine and pyronaridine action on artemisinin ring-stage resistant Kelch C580Y mutation Plasmodium falciparum correlates to hemozoin inhibition process.
    Antimicrob Agents Chemother. 2024 Dec 12:e0120824. doi: 10.1128/aac.01208.
    >> Share

    November 2024
  21. OKITWI M, Shoue DA, Checkley LA, Orena S, et al
    The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates.
    Antimicrob Agents Chemother. 2024 Nov 15:e0118324. doi: 10.1128/aac.01183.
    >> Share

  22. PIERRE-LOUIS E, Kelley J, Patel D, Carlson C, et al
    Geo-classification of drug-resistant travel-associated Plasmodium falciparum using Pfs47 and Pfcpmp gene sequences (USA, 2018-2021).
    Antimicrob Agents Chemother. 2024 Nov 12:e0120324. doi: 10.1128/aac.01203.
    >> Share

    October 2024
  23. HASSANI-ABHARIAN P, Hejazi Dehaghani S, Shahmoradi Z, Hejazi SH, et al
    Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by Leishmania major.
    Antimicrob Agents Chemother. 2024 Oct 24:e0035824. doi: 10.1128/aac.00358.
    >> Share

  24. RIBEIRO JM, Teixeira EdM, Alves LL, Alves EAR, et al
    Can letrozole be repurposed for the treatment of visceral leishmaniasis?
    Antimicrob Agents Chemother. 2024 Oct 10:e0075624. doi: 10.1128/aac.00756.
    >> Share

  25. AMARAL M, Romanelli MM, Asiki H, Bicker J, et al
    Synthesis of a dehydrodieugenol B derivative as a lead compound for visceral leishmaniasis-mechanism of action and in vivo pharmacokinetic studies.
    Antimicrob Agents Chemother. 2024 Oct 9:e0083124. doi: 10.1128/aac.00831.
    >> Share

  26. LOOS JA, Negro PS, Ortega HH, Salinas FJ, et al
    Anti-echinococcal effect of metformin in advanced experimental cystic echinococcosis: reprogrammed intermediary carbon metabolism in the parasite.
    Antimicrob Agents Chemother. 2024;68:e0094124.
    >> Share

    September 2024
  27. AHMED AOA, Nkhoma SC, Zaman S, Rashid S, et al
    In vitro antimalarial susceptibility profile of Plasmodium falciparum isolates in the BEI Resources repository.
    Antimicrob Agents Chemother. 2024 Sep 13:e0118923. doi: 10.1128/aac.01189.
    >> Share

  28. TULLY MK, Dini S, Flegg JA, McCarthy JS, et al
    Evaluation of a Bayesian hierarchical pharmacokinetic-pharmacodynamic model for predicting parasitological outcomes in Phase 2 studies of new antimalarial drugs.
    Antimicrob Agents Chemother. 2024;68:e0086324.
    >> Share

    August 2024
  29. MIN H, Lucky AB, Madsen JJ, Chim-Ong A, et al
    Onametostat, a PfPRMT5 inhibitor, exhibits antimalarial activity to Plasmodium falciparum.
    Antimicrob Agents Chemother. 2024 Aug 28:e0017624. doi: 10.1128/aac.00176.
    >> Share

  30. VYDYAM P, Chand M, Gihaz S, Renard I, et al
    In vitro efficacy of next-generation dihydrotriazines and biguanides against babesiosis and malaria parasites.
    Antimicrob Agents Chemother. 2024 Aug 13:e0042324. doi: 10.1128/aac.00423.
    >> Share

  31. KREUTZFELD O, Orena S, Okitwi M, Tumwebaze PK, et al
    Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates.
    Antimicrob Agents Chemother. 2024 Aug 13:e0046624. doi: 10.1128/aac.00466.
    >> Share

  32. THALOENGSOK S, Chaisatit C, Saingam P, Lertsethtakarn P, et al
    Prevalence and dynamics of antimalarial drug resistance mutations among the Plasmodium falciparum isolates in TAK Province, Thailand, during the period of 1998-2001.
    Antimicrob Agents Chemother. 2024 Aug 13:e0077924. doi: 10.1128/aac.00779.
    >> Share

  33. OGWANG R, Osoti V, Wamae K, Ndwiga L, et al
    A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
    Antimicrob Agents Chemother. 2024 Aug 13:e0157623. doi: 10.1128/aac.01576.
    >> Share

    July 2024
  34. KABECHE S, Braukmann T, Doenier J, Meister T, et al
    A picomolar inhibitor of the Plasmodium falciparum IPP pathway.
    Antimicrob Agents Chemother. 2024 Jul 22:e0123823. doi: 10.1128/aac.01238.
    >> Share

  35. AWOR P, Coppee R, Khim N, Rondepierre L, et al
    Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.
    Antimicrob Agents Chemother. 2024 Jul 19:e0165923. doi: 10.1128/aac.01659.
    >> Share

  36. KAR PP, Araveti PB, Saxena K, Borah A, et al
    Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7.
    Antimicrob Agents Chemother. 2024 Jul 18:e0044024. doi: 10.1128/aac.00440.
    >> Share

    June 2024
  37. ANNAMALAI SUBRAMANI P, Tipthara P, Kolli SK, Nicholas J, et al
    Efficacy of ivermectin and its metabolites against Plasmodium falciparum liver stages in primary human hepatocytes.
    Antimicrob Agents Chemother. 2024 Jun 21:e0127223. doi: 10.1128/aac.01272.
    >> Share

    May 2024
  38. CAJAS RA, Santos SSB, Espirito-Santo MCC, Garedaghi Y, et al
    In vitro and in vivo efficacy of the amiodarone and praziquantel combination against the blood fluke Schistosoma mansoni.
    Antimicrob Agents Chemother. 2024 May 23:e0011424. doi: 10.1128/aac.00114.
    >> Share

    April 2024
  39. SAITO M, Wilaisrisak P, Pimanpanarak M, Viladpai-Nguen J, et al
    Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria.
    Antimicrob Agents Chemother. 2024 Apr 10:e0009324. doi: 10.1128/aac.00093.
    >> Share

  40. AL KHOURY C, Thoumi S, Tokajian S, Sinno A, et al
    ABC transporter inhibition by beauvericin partially overcomes drug resistance in Leishmania tropica.
    Antimicrob Agents Chemother. 2024 Apr 4:e0136823. doi: 10.1128/aac.01368.
    >> Share

    March 2024
  41. SPRINGER E, Heimsch KC, Rahlfs S, Becker K, et al
    Real-time measurements of ATP dynamics via ATeams in Plasmodium falciparum reveal drug-class-specific response patterns.
    Antimicrob Agents Chemother. 2024 Mar 19:e0169023. doi: 10.1128/aac.01690.
    >> Share

  42. YAN M, Liu H, Su Y, Bi X, et al
    Inhibition of AMPK activation in Echinococcus granulosus sensu stricto limits the parasite's glucose metabolism and survival.
    Antimicrob Agents Chemother. 2024;68:e0120223.
    >> Share

    February 2024
  43. SOME AF, Conrad MD, Kabre Z, Fofana A, et al
    Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso.
    Antimicrob Agents Chemother. 2024 Feb 27:e0153423. doi: 10.1128/aac.01534.
    >> Share

  44. ROMAN-ALAMO L, Avalos-Padilla Y, Bouzon-Arnaiz I, Iglesias V, et al
    Effect of the aggregated protein dye YAT2150 on Leishmania parasite viability.
    Antimicrob Agents Chemother. 2024 Feb 13:e0112723. doi: 10.1128/aac.01127.
    >> Share

    January 2024
  45. CHEVALIER FD, Le Clec'h W, Berriman M, Anderson TJ, et al
    A single locus determines praziquantel response in Schistosoma mansoni.
    Antimicrob Agents Chemother. 2024 Jan 30:e0143223. doi: 10.1128/aac.01432.
    >> Share

  46. GREYLING N, van der Watt M, Gwarinda H, van Heerden A, et al
    Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates.
    Antimicrob Agents Chemother. 2024 Jan 23:e0129123. doi: 10.1128/aac.01291.
    >> Share

  47. CHERY-KARSCHNEY L, Patrapuvich R, Mudeppa DG, Kokkonda S, et al
    Tartrolon E, a secondary metabolite of a marine symbiotic bacterium, is a potent inhibitor of asexual and sexual Plasmodium falciparum.
    Antimicrob Agents Chemother. 2024 Jan 9:e0068423. doi: 10.1128/aac.00684.
    >> Share

    December 2023
  48. VAN LOON W, Schallenberg E, Igiraneza C, Habarugira F, et al
    Escalating Plasmodium falciparum K13 marker prevalence indicative of artemisinin resistance in southern Rwanda.
    Antimicrob Agents Chemother. 2023 Dec 11:e0129923. doi: 10.1128/aac.01299.
    >> Share

  49. CRUZ MGFDML, Santi AMM, Morais-Teixeira Ed, Caldeira ASP, et al
    Anti-Leishmania compounds can be screened using Leishmania spp. expressing red fluorescence (tdTomato).
    Antimicrob Agents Chemother. 2023 Dec 8:e0050923. doi: 10.1128/aac.00509.
    >> Share

    November 2023
  50. WATANABE N, Saito-Nakano Y, Kurisawa N, Otomo K, et al
    Fumagillin inhibits growth of the enteric protozoan parasite Entamoeba histolytica by covalently binding to and selectively inhibiting methionine aminopeptidase 2.
    Antimicrob Agents Chemother. 2023;67:e0056023.
    >> Share

  51. NKEMNGO FN, Raissa LW, Nguete DN, Ndo C, et al
    Geographical emergence of sulfadoxine-pyrimethamine drug resistance-associated P. falciparum and P. malariae alleles in co-existing Anopheles mosquito and asymptomatic human populations across Cameroon.
    Antimicrob Agents Chemother. 2023 Nov 10:e0058823. doi: 10.1128/aac.00588.
    >> Share

    October 2023
  52. TOMAZ KCP, Tavella TA, Borba JVB, Salazar-Alvarez LC, et al
    Identification of potential inhibitors of casein kinase 2 alpha of Plasmodium falciparum with potent in vitro activity.
    Antimicrob Agents Chemother. 2023 Oct 11:e0058923. doi: 10.1128/aac.00589.
    >> Share

    September 2023
  53. LUCKY AB, Wang C, Shakri AR, Kalamuddin M, et al
    Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses.
    Antimicrob Agents Chemother. 2023 Sep 13:e0057723. doi: 10.1128/aac.00577.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016